| GALAPAGOS N.V. |
| Belgien |
| Gesundheit |
| BE0003818359 / A0EAT9 |
| GXE (Frankfurt) |
| FRA:GXE, ETR:GXE, GXE:GR |
| AEX |
| https://www.glpg.com/ |
|
Galapagos NV is a fully integrated biotechnology c..
>Volltext.. |
| 1741.17 Mio. EUR |
| -1356.98 Mio. EUR |
| 281.91 Mio. EUR |
| - |
| -290.78 Mio. EUR |
| -4.41 EUR |
| 8.64 Mio. EUR |
| 95.63 Mio. EUR |
| -221.22 Mio. EUR |
| 7.73 |
| -50.8% |
| -80.67% |
| - |
| - |
| - |
| - |
| GALAPAGOS |
| 06.11.25 |
|
||||
|
||||
|